4//SEC Filing
Loh Evan 4
Accession 0000904454-23-000472
CIK 0001178711other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 8:26 PM ET
Size
7.2 KB
Accession
0000904454-23-000472
Insider Transaction Report
Form 4
Loh Evan
DirectorSee Remarks
Transactions
- Award
Common Stock
2023-08-08+168,750→ 1,376,948 total - Sale
Common Stock
2023-08-09$2.20/sh−48,967$107,727→ 1,327,981 total
Footnotes (3)
- [F1]Represents performance-based restricted stock units ("PRSUs") granted on March 30, 2021 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2023.
- [F2]Sale of shares to cover personal income tax obligations upon vesting of PRSUs.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.19 to $2.21. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
Documents
Issuer
Paratek Pharmaceuticals, Inc.
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001622680
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 8:26 PM ET
- Size
- 7.2 KB